Ptc Therapeutics (PTCT) Change in Receivables (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Change in Receivables of $19.7 million for Q2 2026, up 190.08% year-over-year from $6.8 million in Q2 2025, and down 51.16% quarter-over-quarter from $40.4 million in Q1 2026.
Ptc Therapeutics (PTCT) Change in Receivables (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Change in Receivables history runs 15 years deep, the most recent figure standing at $19.7 million for Q2 2026.
- In Q2 2026, Change in Receivables rose 190.08% year-over-year to $19.7 million; the TTM figure through Jun 2026 stood at $44.4 million (up 720.58% YoY), while the FY2025 annual figure was $10.2 million, up 686.09% from the prior year.
- Change in Receivables for Q2 2026 stood at $19.7 million, down from $40.4 million in the prior quarter.
- The five-year high for Change in Receivables was $47.8 million in Q1 2025, with the low at -$40.8 million in Q4 2024.
- The 5-year median for Change in Receivables is $3.8 million (2022), against an average of $6.6 million.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables sank 2258.37% in 2023, then soared 194.89% in 2024.
- Ptc Therapeutics' Change in Receivables stood at $23.7 million in 2022, then sank by 135.23% to -$8.3 million in 2023, then tumbled by 388.27% to -$40.8 million in 2024, then surged by 45.5% to -$22.2 million in 2025, then surged by 188.81% to $19.7 million in 2026.
- Business Quant data shows PTCT's Change in Receivables at $19.7 million in Q2 2026, $40.4 million in Q1 2026, and -$22.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 19.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.73 Mn |
| Jun 30, 2026 | 19.73 Mn |
| Mar 31, 2026 | 40.39 Mn |
| Mar 31, 2026 | 40.39 Mn |
| Dec 31, 2025 | -22.21 Mn |
| Dec 31, 2025 | -22.21 Mn |
| Sep 30, 2025 | 6.47 Mn |
| Sep 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | -21.90 Mn |
| Jun 30, 2025 | -21.90 Mn |
| Mar 31, 2025 | 47.79 Mn |
| Mar 31, 2025 | 47.79 Mn |
| Dec 31, 2024 | -40.76 Mn |
| Dec 31, 2024 | -40.76 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | -8.19 Mn |
| Jun 30, 2024 | -8.19 Mn |
| Mar 31, 2024 | 39.50 Mn |
| Mar 31, 2024 | 39.50 Mn |